S.lab (soloways)

This study tested a protein called GcMAF in 120 people with chronic inflammatory diseases like rheumatoid arthritis or cystitis that didn't respond to standard treatments. The goal was to see if it is safe and can reduce inflammation. The study had two parts: first, finding a saf…

This early-stage study tested a new drug called EF-M2 in 48 adults with moderate-to-severe rheumatoid arthritis. The drug is designed to reprogram immune cells to reduce inflammation. The main goal was to check safety and how the body reacts to the drug, with a focus on finding t…

This study tested a new type of group therapy called Terebenin's Method for adults with mild to moderate anxiety and depression. 66 people took part, with half receiving the therapy and half in a control group. The goal was to see if this therapy reduces symptoms and improves wel…